$9.260
+0.215 (+2.32%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NVAX Prediction & Forecast by Similar Chart Analysis
Alphio's NVAX stock price prediction model matches the current Novavax Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.37 (+1.24%). The 1-week path is $9.24 (-0.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Novavax Inc Stock?
Novavax Inc is a good buy right now due to its recent vaccine approvals which are expected to generate significant revenue. The current price is $9.26, with a forward P/E ratio of 2.58 indicating potential for growth. Additionally, the stock has shown a year-to-date change of +29.87%, reflecting strong market sentiment. However, the main risk is its recent financial performance, particularly a net income loss of $53.39 million in Q2 2026, which could affect future profitability.
NVAX stock price ended at $9.26 on Friday, after rising +2.32%
Novavax Inc (NVAX) last closed at $9.26, gaining +2.32%. These facts feed the 1-day and 1-week NVAX price prediction above.
Analyst Consensus
Novavax Inc (NVAX): 2 buy, 5 hold, 0 sell. Outlook: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Novavax Inc (NVAX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches NVAX, ranked by similarity.
Seasonality analysis for NVAX
Historically the probability of a positive August return for NVAX is 77.78%. October offers the highest probability of a positive month at 78.26%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NVAX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $16.73 | $17.70 | $19.39 | +91.12% |
| Sep 2026 | $12.76 | $15.20 | $16.73 | +64.17% |
| Oct 2026 | $6.81 | $14.48 | $20.23 | +56.36% |
| Nov 2026 | $13.30 | $16.55 | $24.49 | +78.77% |
| Dec 2026 | $4.06 | $10.95 | $12.67 | +18.29% |
In 2026, Novavax Inc (NVAX) is projected to range from $4.06 to $24.49.
Novavax Inc 2026 monthly forecast
In Aug 2026, Novavax Inc is projected to average $17.70, with a low of $16.73 and high of $19.39.
In Sep 2026, Novavax Inc is projected to average $15.20, with a low of $12.76 and high of $16.73.
In Oct 2026, Novavax Inc is projected to average $14.48, with a low of $6.81 and high of $20.23.
In Nov 2026, Novavax Inc is projected to average $16.55, with a low of $13.30 and high of $24.49.
In Dec 2026, Novavax Inc is projected to average $10.95, with a low of $4.06 and high of $12.67.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.